These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 22248589

  • 1. Roles of extracellular chaperones in amyloidosis.
    Wyatt AR, Yerbury JJ, Dabbs RA, Wilson MR.
    J Mol Biol; 2012 Aug 24; 421(4-5):499-516. PubMed ID: 22248589
    [Abstract] [Full Text] [Related]

  • 2. Extracellular chaperones.
    Dabbs RA, Wyatt AR, Yerbury JJ, Ecroyd H, Wilson MR.
    Top Curr Chem; 2013 Aug 24; 328():241-68. PubMed ID: 22076079
    [Abstract] [Full Text] [Related]

  • 3. Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins.
    Naiki H, Nagai Y.
    J Biochem; 2009 Dec 24; 146(6):751-6. PubMed ID: 19643812
    [Abstract] [Full Text] [Related]

  • 4. [Amyloidosis: a model of misfolded protein disorder].
    Grateau G, Verine J, Delpech M, Ries M.
    Med Sci (Paris); 2005 Dec 24; 21(6-7):627-33. PubMed ID: 15985206
    [Abstract] [Full Text] [Related]

  • 5. Extracellular chaperones and proteostasis.
    Wyatt AR, Yerbury JJ, Ecroyd H, Wilson MR.
    Annu Rev Biochem; 2013 Dec 24; 82():295-322. PubMed ID: 23350744
    [Abstract] [Full Text] [Related]

  • 6. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation.
    Nerelius C, Fitzen M, Johansson J.
    Biochem Biophys Res Commun; 2010 May 21; 396(1):2-6. PubMed ID: 20494101
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chapter 6: The chaperone action of Clusterin and its putative role in quality control of extracellular protein folding.
    Wyatt A, Yerbury J, Poon S, Dabbs R, Wilson M.
    Adv Cancer Res; 2009 May 21; 104():89-114. PubMed ID: 19878774
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clearance of extracellular misfolded proteins in systemic amyloidosis: experience with transthyretin.
    Almeida MR, Saraiva MJ.
    FEBS Lett; 2012 Aug 31; 586(18):2891-6. PubMed ID: 22819819
    [Abstract] [Full Text] [Related]

  • 15. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
    Chiti F, Dobson CM.
    Annu Rev Biochem; 2017 Jun 20; 86():27-68. PubMed ID: 28498720
    [Abstract] [Full Text] [Related]

  • 16. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
    Huang L, Liu X, Cheng B, Huang K.
    Arch Biochem Biophys; 2015 Feb 15; 568():46-55. PubMed ID: 25615529
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of neurodegeneration by molecular chaperones.
    Muchowski PJ, Wacker JL.
    Nat Rev Neurosci; 2005 Jan 15; 6(1):11-22. PubMed ID: 15611723
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.